Sponsor Pipeline

Milton S. Hershey Medical Center Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
79
Active Trials
44
Recruiting
2
Phase 3
10
Disease Areas
17
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT06273618
iLookOut Micro-learning to Improve Knowledge Retention
Enrollment closed, study ongoing
2026-08-15 NCT01606826
Severe Asthma Research Program
Trial completed
2026-08-15 NCT01606826
Severe Asthma Research Program
date change Primary completion pushed: 2026-06-30 -> 2026-07-31
2026-08-15 NCT01606826
Severe Asthma Research Program
date change Completion moved earlier: 2026-12-31 -> 2026-07-31
2026-08-15 NCT04324619
iLookOut for Child Abuse: Micro-learning to Improve Knowledge Retention
Enrollment closed, study ongoing
2026-08-14 NCT03921944
Evaluation of Structural and Functional Integrity of the Rotator Cuff After Total…
date change Primary completion pushed: 2027-09 -> 2028-09
2026-08-14 NCT03921944
Evaluation of Structural and Functional Integrity of the Rotator Cuff After Total…
date change Completion pushed: 2027-12 -> 2028-12
2026-08-13 NCT04987879
NASH AMPK Exercise Dosing (AMPED) Trial
Trial completed
2026-08-13 NCT04987879
NASH AMPK Exercise Dosing (AMPED) Trial
Enrollment reduced: 45 -> 20 participants
2026-08-13 NCT04987879
NASH AMPK Exercise Dosing (AMPED) Trial
date change Primary completion moved earlier: 2026-05-31 -> 2026-02-10
2026-08-13 NCT04987879
NASH AMPK Exercise Dosing (AMPED) Trial
date change Completion moved earlier: 2026-07-15 -> 2026-02-10
2026-08-13 NCT07540052
Impact of Loss Aversion Messaging and Anticipated Regret for Inaction on Exercise…
date change Primary completion pushed: 2027-06 -> 2027-12
2026-08-13 NCT07540052
Impact of Loss Aversion Messaging and Anticipated Regret for Inaction on Exercise…
date change Completion pushed: 2027-07 -> 2028-01
2026-07-30 NCT04386005
Continuous Glucose Monitoring in At-Risk Newborns
Trial completed
2026-07-30 NCT04386005
Continuous Glucose Monitoring in At-Risk Newborns
Enrollment reduced: 100 -> 50 participants
2026-07-25 NCT06548490
GLP-1R Agonist Treatment for Opioid Use Disorder
date change Primary completion pushed: 2026-11 -> 2027-04
2026-07-25 NCT06548490
GLP-1R Agonist Treatment for Opioid Use Disorder
date change Completion pushed: 2026-11 -> 2027-04
Active Trials by Phase
Phase 4
3
Phase 2/3
2
Phase 2
3
Phase 1/2
3
Phase 1
1
Early Phase 1
7
Not specified
60
Active Trials — top 25 of 79
NCT IDTitleConditionStatus
Phase 4
NCT06871488 Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated… ADHD - Attention Deficit Disorder With Hyperactivity Recruiting
NCT03737292 Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain… Pain, Postoperative Recruiting
NCT07030933 Amino Acid Infusion in Cardiac Surgery Acute Kidney Injury Not Yet Recruiting
Phase 2/3
NCT06396247 Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical… Mobility Limitation Recruiting
NCT04802408 SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial Covid19 Active, Not Recruiting
Phase 2
NCT06926595 Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention Graft-versus-Host Disease (GVHD) Recruiting
NCT07321912 Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma Osteosarcoma Recruiting
NCT06548490 GLP-1R Agonist Treatment for Opioid Use Disorder Opioid Use Disorder Recruiting
Phase 1/2
NCT06600698 Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA Prostate Cancer Recruiting
NCT06541262 Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid… Neuroblastoma Recruiting
NCT06465199 Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas Atypical Teratoid/Rhabdoid Tumor Recruiting
Phase 1
NCT07016971 CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy Chemotherapy-Induced Peripheral Neuropathy Recruiting
Early Phase 1
NCT05301192 Angiotensin-(1-7) Cardiovascular Effects in Aging Aging Recruiting
NCT06482853 Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension Obesity Recruiting
NCT06281756 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Insomnia Recruiting
NCT03513770 Autonomic Control of the Circulation and VDR Venous Distension Reflex Recruiting
NCT05239793 Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects Chronic Obstructive Pulmonary Disease Active, Not Recruiting
NCT06369363 Estrogen Deficiency on Cardiovascular Risk Postmenopausal Symptoms Not Yet Recruiting
NCT06369350 Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion Ischemia Reperfusion Injury Not Yet Recruiting
Not specified
NCT06085092 Open vs. Blind Weighing Study In Adolescents and Young Adult With Eating Disorders Eating Disorders Recruiting
NCT06043362 Use of Nicotine Pouches Among Daily Smokers Tobacco Dependence Recruiting
NCT05197920 Diabetes RElated to Acute Pancreatitis and Its Mechanisms Acute Pancreatitis Recruiting
NCT06107816 A Fruit and Vegetable Prescription Program Diabetes Mellitus Recruiting
NCT06141720 Feasibility of a Mindfulness Intervention for Endometriosis Surgery Endometriosis Recruiting
NCT05998629 Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic… Cystic Fibrosis Recruiting
See all 79 active Milton S. Hershey Medical Center trials with filters →
Disease Areas
Get alerts when Milton S. Hershey Medical Center's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free